Lantheus confirms patent infringement lawsuit by Novartis over generic Lutetium Lu 177 Dotatate ANDA

Lantheus Holdings, Inc.

Lawsuit filed by Advanced Accelerator Applications (Novartis entities) in U.S. District Court for Delaware against Lantheus and its subsidiary.
Suit stems from Lantheus's ANDA No. 217060 for generic version of LUTATHERA (lutetium Lu 177 dotatate) for GEP-NETs.
Lantheus believes it is the 'first applicant' and eligible for 180 days of generic marketing exclusivity in the U.S.
No financial impact or settlement terms disclosed in this filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.